Anxiety Disorders, Dysphonia, Fibromyalgia
Conditions
Keywords
anxiety, fibromyalgia, dysphonia
Brief summary
Our aim in conducting this study is to determine the relationship between voice disorders and anxiety in patients with fibromyalgia syndrome (FS).
Detailed description
This case controlled study was performed at the Physical Medicine and Rehabilitation outpatient clinic between April 2022 and June 2022. 25 patients who were diagnosed with FS according to the 2010 American College of Rheumatology (ACR) criteria were included in the study. For the control group 25 healthy volunteers with no previous chronic disease history were included . The investigators planed to investigate the relationship between the anxiety level of the FS patients and dysphonia. Thus an acoustic voice analysis (fundamental frequency (F0), jitter, shimmer, noise to harmonic ratio (NHR), harmonic to noise ratio (HNR)) and an aerodynamic analysis (maximal phonation time (MPT)) were performed by an experienced otolaryngologist specialized in voice disorders for evaluation of objective voice quality and function. These analyses were performed on all the volunteers from both groups, and the results obtained were compared between the groups.
Interventions
DIAGNOSTIC_TESTAssessment of Voice Quality and Function
An acoustic voice analysis (fundamental frequency (F0), jitter, shimmer, noise to harmonic ratio (NHR), harmonic to noise ratio (HNR)) and an aerodynamic analysis (maximal phonation time (MPT)) were performed by an experienced otolaryngologist specialized in voice disorders for evaluation of objective voice quality and function. These analyses were performed on all the volunteers from both groups, and the results obtained were compared between the groups.
Sponsors
Umraniye Education and Research Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Diagnosed with Fibromyalgia syndrome for at least 1 year * Minimum VAS score of 3
Exclusion criteria
* Patients with diabetes mellitus, * other rheumatological diseases, * malignancies, * connective tissue disorders * neuromuscular diseases and * hereditary diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Beck Anxiety Questionary Score | at the start of the study | Measuring The Anxiety level, It is scored between 0-63. The greater the score the greater the anxiety level of the subject. |
| Visual Analogue Scale (VAS) Score | at the start of the study | Visual Analogue Scale is used to measure the pain level of the subjects. It is scored between 0 to 10. Greater score corresponds to greater pain sensation. |
Countries
Turkey (Türkiye)
Outcome results
None listed